- Home
- TLSI vs ARL Comparison
TLSI vs ARL Comparison
Compare TLSI & ARL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TLSI | ARL |
|---|---|---|
| Founded | 2010 | 1999 |
| Country | United States | United States |
| Employees | 110 | N/A |
| Industry | Medical Specialities | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 267.1M | 268.4M |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | TLSI | ARL |
|---|---|---|
| Price | $4.16 | $16.23 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 198.2K | 2.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.37 |
| Revenue | N/A | ★ $47,318,000.00 |
| Revenue This Year | $41.93 | N/A |
| Revenue Next Year | $41.75 | N/A |
| P/E Ratio | ★ N/A | $44.59 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.42 | $9.43 |
| 52 Week High | $7.95 | $20.00 |
Technical Indicators
Market Signals| Indicator | TLSI | ARL |
|---|---|---|
| Relative Strength Index (RSI) | 35.61 | 41.28 |
| Support Level | $3.61 | $14.95 |
| Resistance Level | $5.51 | $16.89 |
| Average True Range (ATR) | 0.39 | 0.36 |
| MACD | -0.06 | -0.09 |
| Stochastic Oscillator | 7.22 | 8.28 |
Price Performance
Historical ComparisonAbout TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About ARL American Realty Investors Inc.
American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments; the acquisition, development, ownership and management of multifamily properties (Residential); and the acquisition, development, ownership, and management of commercial properties (Commercial), which predominantly comprise office properties. Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.